4,4'-DDE (13C12)(201612-50-2)
- Name: 4,4'-DDE (13C12)
- Synonyms:4,4'-DDE (Ring-13C12, 99%);4,4'-DDE (13C12);4,4'-DDE (RING-13C12);(P,P'-DICHLORODIPHENYL)DICHLOROETHYLENE (RING-13C12);P,P'-DDE-13C12;4,4'-DDE-13C12 in n-nonane;p,p'-DDE-13C12;4,4′-DDE (ring-13C??, 99%)
- Molecular Formula:C14H8Cl4
- Molecular Weight:330.13
- CAS Registry Number:201612-50-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 201546-82-9/Propanimidamide, N-hydroxy-3-(phenylmethoxy)-
- 2015655-98-6/tert-Butyl 2-(2-Methyl-1-pyrrolidinyl)acetate
- 2015677-85-5/5-Bromo-2-(3,3-difluoropiperidin-1-yl)aniline
- 201595-54-2/[U-Ring-13C6]-3-Hydroxy-4-methoxybenzoic acid
- 201595-62-2/VZCYOOQTPOCHFL-BHBLSLFXSA-N
- 201595-66-6/[U-Ring-13C6]-1-Chloro-4-nitrobenzene
- 201596-42-1/1-iodo-3-(propan-2-yloxy)propan-2-ol
- 2015995-56-7/INDEX NAME NOT YET ASSIGNED
- 201600-23-9/Carbamic acid, [2-(chloromethyl)phenyl]- (9CI)
- 2016010-93-6/3,4-Di-9H-carbazol-9-ylbenzonitrile
- 201601-32-3/2-((4aS,4bS,5aS,6aS,7R,8R,9aS,9bS)-7-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl 4-methylbenzenesulfonate
- 201605-27-8/10-O-trans-p-methoxycinnamoyl-catalpol
- 201608-12-0/Cell-permeable Caspase-1 Inhibitor I trifluoroacetate salt
- 201608-15-3/Cell-permeable Caspase-3 Inhibitor I trifluoroacetate salt
- 201608-17-5/NF-κB Control
- 201608-18-6/Prostaglandin A2-d4
- 201610-16-4/1,4,8,11- tetra(trifluoroacetyl)-1,4,8,11-tetraazacyclotetradecane
- 201611-88-3/(4-Ethenylphenyl)methyl benzenecarbodithioate
- 201612-49-9/CHLORAL HYDRATE (TRICHLOROMethyl-13C)
- 201612-50-2/4,4'-DDE (13C12)
- 201612-56-8/WKOLLVMJNQIZCI-WBJZHHNVSA-N
- 201612-59-1/L-Cysteine-N-t-Boc, S-benzyl (3-13C)
- 201612-60-4/L-Glutamine-N-t-Boc (1,2-13C2, 99%)
- 2016319-35-8/tert-butyl 4-(methoxymethyl)piperidine-4-carboxylate
- 20163-36-4/Cyclohexanone, 2-(3-hydroxyphenyl)-2-(methylamino)-
- 2016539-73-2/3-Pyrrolidinemethanol, 1-[(2-fluorophenyl)methyl]-4-hydroxy-
- 201654-51-5/Quinoline, 1,2,3,4-tetrahydro-2-methyl-7-nitro-2-propyl-
- 201664-34-8/1,3-Benzenediol, 5-[1-hydroxy-2-[[1-methyl-2-[4-(sulfooxy)phenyl]ethyl]amino]ethyl]-
- 201665-18-1/Methanesulfonic acid, 1,1,1-trifluoro-, 1,1'-(oxydi-2,1-ethanediyl) ester
- 201668-33-9/FLUFENACET METABOLITE FOE5043